Wave Life Sciences has plummeted after two Wall Street firms cut price targets following updated trial data for the company's ...
Wave Life Sciences Ltd. (NASDAQ:WVE) shares fell 30% Thursday following the company’s announcement of interim Phase 1 data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results